Democrats' Last Chance for Drug Pricing Reform?
July 20 at 1 p.m. ET / 10 a.m. PT
Once again Congress is barreling towards drug pricing reform, STAT will sit down with key decision makers to talk about the latest developments from Capitol Hill and the White House.
- Richard G. Frank, Ph.D., director of the USC-Brookings Schaeffer Initiative on Health Policy; fellow in economic studies; Margaret T. Morris professor of health economics, emeritus, department of health care policy, Harvard Medical School
- Rachel Cohrs, Washington correspondent, STAT (moderator)
- Brent Dover, CEO, Kalderos (sponsor speaker)